BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 67712)

  • 1. Serial infusion effects of hydroxyethyl starch on ESR, blood typing and crossmatching and serum amylase levels.
    Janes AW; Mishler JM; Lowes B
    Vox Sang; 1977; 32(3):131-4. PubMed ID: 67712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects produced by the acute and chronic administration of hydroxyethyl starch.
    Mishler JM
    J Clin Apher; 1984; 2(1):52-62. PubMed ID: 6085628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macroamylasaemia following the infusion of low molecular weight-hydroxyethyl starch in man.
    Mishler JM; Dürr HK
    Eur Surg Res; 1979; 11(4):217-22. PubMed ID: 93539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Second increase in plasma volume after single infusion of hydroxyethyl starch (author's transl)].
    Köhler H; Kirch W; Pitz H
    Klin Wochenschr; 1978 Oct; 56(19):977-83. PubMed ID: 81905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravascular persistence of hydroxyethyl starch in man.
    Boon JC; Jesch F; Ring J; Messmer K
    Eur Surg Res; 1976; 8(6):497-503. PubMed ID: 65282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hydroxyethyl starch on erythrocyte typing and blood crossmatching.
    Daniels MJ; Strauss RG; Smith-Floss AM
    Transfusion; 1982; 22(3):226-8. PubMed ID: 6178192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of intravenous infusions of hydroxyethylstarch (HES) (MW 40,000 and 450,000) on the blood flow properties of healthy volunteers.
    Ehrly AM; Landgraf H
    Angiology; 1985 Jan; 36(1):41-4. PubMed ID: 2411169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macroamylasaemia after treatment with hydroxyethyl starch.
    Köhler H; Kirch W; Weihrauch TR; Prellwitz W; Horstmann HJ
    Eur J Clin Invest; 1977 Jun; 7(3):205-11. PubMed ID: 70354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of hydroxyethyl starch on the flow properties of human erythrocyte suspensions.
    Corry WD; Jackson LJ; Seaman GV
    Biorheology; 1983; 20(5):705-17. PubMed ID: 6203575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macroamylasemia induced by hydroxyethyl starch--confirmation by gel filtration analysis of serum and urine.
    Mishler JM; Dürr GH
    Am J Clin Pathol; 1980 Oct; 74(4):387-91. PubMed ID: 6158858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyethyl starch: an agent for hypovolemic shock treatment.
    Mishler JM; Borberg H; Emerson PM; Gross R
    J Surg Res; 1977 Oct; 23(4):239-45. PubMed ID: 70572
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of hydroxyethyl starch in normal subjects.
    Yacobi A; Stoll RG; Sum CY; Lai CM; Gupta SD; Hulse JD
    J Clin Pharmacol; 1982 Apr; 22(4):206-12. PubMed ID: 6178760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The plasma kinetics of hydroxyethyl starch 350/0.60: a potential new adjunct for centrifugal leucapheresis.
    Mishler JM
    Am J Hematol; 1979; 7(4):341-7. PubMed ID: 94771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII.
    Stump DC; Strauss RG; Henriksen RA; Petersen RE; Saunders R
    Transfusion; 1985; 25(4):349-54. PubMed ID: 2411030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyethyl starch. An agent for hypovolaemic schock treatment II. Urinary excretion in normal volunteers following three consecutive daily infusions.
    Mishler JM; Borberg H; Emerson PM; Gross R
    Br J Clin Pharmacol; 1977 Oct; 4(5):591-5. PubMed ID: 71913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of leucocyte-poor red blood cell suspensions prepared by sedimentation in hydroxyethyl starch.
    Dorner I; Moore JA; Collins JA; Sherman LA; Chaplin H
    Transfusion; 1975; 15(5):439-48. PubMed ID: 53916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the effects of hydroxyethyl starch on the blood coagulation system.
    Strauss RG
    Transfusion; 1981; 21(3):299-302. PubMed ID: 6165107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparison of the erythrocyte sedimenting properties of dextran, hydroxyethyl starch and a new low-molecular-weight hydroxyethyl starch.
    Strauss RG
    Vox Sang; 1979; 37(5):268-71. PubMed ID: 93347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography.
    Jamnicki M; Zollinger A; Seifert B; Popovic D; Pasch T; Spahn DR
    Anesth Analg; 1998 Nov; 87(5):989-93. PubMed ID: 9806670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunteers (author's transl)].
    Köhler H; Zschiedrich H; Clasen R; Linfante A; Gamm H
    Anaesthesist; 1982 Feb; 31(2):61-7. PubMed ID: 6177264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.